Issue 1/2008
Content (130 Articles)
Clinical study
Bisphosphonates NOT associated with atrial fibrillation
Correspondence
US Prezista label: hepatotoxicity warning added
News item
PML reported with CellCept
Media release
Possible stroke risk with Spiriva
Clinical study
Cetuximab hypersensitivity associated with IgE antibodies
News item
Drug safety laws tightened in the UK
Case report
Adalimumab
Case report
Allergens
Case report
Adalimumab
Case report
Acetylcysteine
Case report
Anastrozole
Case report
Amoxicillin/diltiazem
Case report
Amoxicillin
Case report
Amoxicillin
Case report
Amoxicillin
Case report
Antibacterials
Case report
Antipsychotics
Case report
Antineoplastics
Case report
Bevacizumab
Case report
Antiretrovirals
Case report
Aspirin
Case report
Bevacizumab/capecitabine/oxaliplatin
Case report
Bupropion
Case report
Budesonide
Case report
Bupivacaine/lidocaine
Case report
Carbamazepine/lithium overdose
Case report
Carbamazepine
Case report
Carbamazepine
Case report
Cephalosporins
Case report
Carboplatin
Case report
Cefpodoxime
Case report
Ceftazidime/cotrimoxazole/vancomycin
Case report
Cetuximab
Case report
Ciprofloxacin
Case report
Chlorambucil
Case report
Cetirizine
Case report
Clonixin
Case report
Codeine
Case report
Dantron/sodium dioctyl sulfosuccinate
Case report
Corticosteroids
Case report
Cyclopentolate
Case report
Dexamethasone
Case report
Desflurane
Case report
Diclofenac
Case report
Epinephrine
Case report
Diltiazem
Case report
Dibucaine
Case report
Docetaxel
Case report
Erlotinib
Case report
Fibrin sealant
Case report
Etoricoxib
Case report
Etanercept
Case report
Etanercept
Case report
Furosemide abuse
Case report
Formaldehyde
Case report
Gadoterate meglumine
Case report
Folic acid
Case report
Gemcitabine
Case report
Grass pollen allergy vaccine
Case report
Griseofulvin
Case report
Ginseng
Case report
Hyaluronic acid
Case report
Herbal medicines
Case report
Hepatitis B vaccine recombinant
Case report
Heparin
Case report
Histamine H1 receptor antagonists
Case report
Immunosuppressants
Case report
Immunotherapies
Case report
Icatibant
Case report
Ibuprofen
Case report
Isotretinoin
Case report
Interferon-α-2b
Case report
Lamotrigine
Case report
Levofloxacin
Case report
Iohexol
Case report
Mesalazine
Case report
Meglumine antimonate
Case report
Levothyroxine sodium
Case report
Methylthioninium chloride
Case report
Methotrexate
Case report
Methylphenidate
Case report
Methylprednisolone
Case report
Methylphenidate
Case report
Nicorandil
Case report
Montelukast
Case report
Nadroparin calcium
Case report
Metronidazole
Case report
Midazolam
Case report
Mizolastine
Case report
Octreotide
Case report
Omalizumab
Case report
Nimesulide
Case report
Normal human immunoglobulin
Case report
Omalizumab
Case report
Omeprazole
Case report
Oxaliplatin
Case report
Oxcarbazepine
Case report
Peginterferon-α-2a
Case report
Paracetamol interaction
Case report
Paclitaxel
Case report
Paracetamol
Case report
Pemetrexed
Case report
Phenytoin
Case report
Povidone iodine
Case report
Phenylephrine
Case report
Propafenone
Case report
Sodium oxybate withdrawal
Case report
Prednisone
Case report
Sorafenib/sunitinib
Case report
Sodium phosphate
Case report
Sumatriptan
Case report
Testosterone supplements
Case report
Tetrazepam
Case report
Timolol
Case report
Thiethylperazine
Case report
Teicoplanin
Case report
Sumatriptan
Case report
Valproic acid
Case report
Tramadol
Case report
Venlafaxine
Case report
Tixocortol
Case report
Trastuzumab
Case report